SCHEMBL3207845

SCHEMBL3207845

Cc1ccc(-n2cccc2/C=C/C(=O)CC(=O)/C=C/c2cccn2-c2ccc(C)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 4/20 0.44
MAPT P10636 6/20 0.43
KMT2A Q03164 5/20 0.43
TDP1 Q9NUW8 4/20 0.43
MEN1 O00255 3/20 0.43
RAB9A P51151 2/20 0.43
NPC1 O15118 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
GAA P10253 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
POLB P06746 5/20 0.43
KDM4E B2RXH2 4/20 0.43
HPGD P15428 2/20 0.42
APEX1 P27695 2/20 0.42
BLM P54132 2/20 0.42
MCL1 Q07820 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
TNNI3 P19429 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3207853 1.00 RECQL (0.44) RECQLMAPTKMT2ATDP1MEN1
SCHEMBL3207683 0.90 MAOB (0.54) MAPTKMT2ARAB9APOLBLMNA
SCHEMBL3207697 0.90 MAOB (0.54) MAPTKMT2ARAB9APOLBLMNA
SCHEMBL13213481 0.75 HDAC1 (0.57) LMNA
SCHEMBL3211700 0.75 ATM (0.69) RECQLMAPTKMT2ATDP1MEN1
SCHEMBL14788055 0.73 MAPT (0.72) RECQLMAPTKMT2ATDP1MEN1
SCHEMBL1233090 0.71 PKM (0.47) RECQLMAPTKMT2ATDP1MEN1
SCHEMBL1233089 0.71 PKM (0.47) RECQLMAPTKMT2ATDP1MEN1
SCHEMBL16204335 0.70 RECQL (0.57) RECQLMAPTKMT2ATDP1MEN1
SCHEMBL15177185 0.69 L3MBTL1 (0.73) MAPTKMT2ATDP1MEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962674-B2 Curcumin derivative TOKYO INSTITUTE OF TECHNOLOGY (JP) 2015-02-24 US disclosed
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE TOKYO INSTITUTE OF TECHNOLOGY (JP) 2010-02-25 US disclosed
EP-2123637-A1 NOVEL CURCUMIN DERIVATIVE Tokyo Institute of Technology (JP) 2009-11-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE BACE1, APP, BACE2 RECQL 4001/4885MAPT 8/4885KMT2A 2031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.